PARP inhibition induces a redox-dependent dormant reservoir vulnerable to disulfiram in high-grade serous ovarian cancer
Open Access
- 5 August 2026
- journal article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 202, 119821
Abstract
No abstract availableKeywords
Funding Information
- Faculty of Medicine Siriraj Hospital, Mahidol University
- Mahidol University (R016620002)
This publication has 40 references indexed in Scilit:
- Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trialAnnals of Oncology, 2024
- Dormant cancer cells and polyploid giant cancer cells: The roots of cancer recurrence and metastasisClinical and Translational Medicine, 2024
- Comprehensive drug response profiling and pan-omic analysis identified therapeutic candidates and prognostic biomarkers for Asian cholangiocarcinomaiScience, 2022
- When breaks get hot: inflammatory signaling in BRCA1/2-mutant cancersTrends in Cancer, 2022
- Mechanism of Drug Tolerant Persister Cancer Cells: The Landscape and Clinical Implication for TherapyJournal of Thoracic Oncology, 2021
- Disulfiram modulates ROS accumulation and overcomes synergistically cisplatin resistance in breast cancer cell linesBiomedicine & Pharmacotherapy, 2019
- Mechanisms of Drug Resistance in High-Grade Serous Ovarian CancerHematology/Oncology Clinics of North America, 2018
- Reverse Phase Protein Arrays for Compound ProfilingCurrent Protocols in Chemical Biology, 2016
- N,N-diethylaminobenzaldehyde (DEAB) as a substrate and mechanism-based inhibitor for human ALDH isoenzymesChemico-Biological Interactions, 2015
- Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44+ human breast cancer cellsBreast Cancer Research and Treatment, 2011